Tag: Therapeutics

Feldan Therapeutics Receives Investment from Zynext Ventures

Feldan Therapeutics, a Québec Metropolis, Québec, Canada-based early clinical-stage pharmaceutical firm, obtained an funding from Zynext Ventures. The quantity

By saad

Atsena Therapeutics Raises $150M in Series C Financing

Atsena Therapeutics, a Durham, NC-based clinical-stage gene remedy firm, raised $150M in Collection C funding. The spherical was

By saad

Augustine Therapeutics Raises EUR 77.7M in Series A Funding

Augustine Therapeutics, a Leuven, Belgium-based biotechnology firm centered on creating new therapies by means of the inhibition of

By saad

Montara Therapeutics Closes $20M Seed Expansion

Montara Therapeutics, a San Francisco, CA-based biotech firm empowering brain-selective therapies for CNS illnesses, raised $20M in Seed

By saad

Illexcor Therapeutics Receives Investment From Zynext Ventures

Illexcor Therapeutics, a Richmond, VA-based biopharmaceutical firm growing new oral therapies for sickle cell illness (SCD), acquired an

By saad

Mair Therapeutics Raises Pre-Seed Funding

Mair Therapeutics, a Nijmegen, the Netherlands-based biotechnology startup growing remedies for neurodegenerative problems, raised an undisclosed quantity in

By saad

Newleos Therapeutics Raises $93.5M in Series A Financing

Newleos Therapeutics, Inc., a Boston, MA-based medical stage neuroscience firm co-founded by Longwood Fund and seasoned leaders in

By saad

Miist Therapeutics Raises $7M in Funding

Miist Therapeutics, an Alameda CA-based physics-based developer of inhaled medicines, raised $7M in funding. Backers included Refactor Capital,

By saad

Timberlyne Therapeutics Raises $180M in Series A Funding

Timberlyne Therapeutics, a San Diego, CA-based clinical-stage biopharmaceutical firm targeted on the event of recent therapies for autoimmune

By saad

Light Horse Therapeutics Raises $62M in Series A Financing

Light Horse Therapeutics, a San Diego, CA-based developer of small molecule therapeutics, raised $62M in Sequence A funding.

By saad

Neumirna Therapeutics Raises €20M in Series A Funding

Neumirna Therapeutics, a Copenhagen, Denmark-based RNA-focused biotech firm, raised €20M in Collection A funding. The spherical was led

By saad

Tenvie Therapeutics Raises $200M in Funding

Tenvie Therapeutics, a San Francisco, CA-based biotechnology firm dedicated to engineering small molecules for the therapy of neurological

By saad